All In Biotech

Drug Trial Radar · NCT02693535

TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer

Targeted Agent and Profiling Utilization Registry (TAPUR) Study

Last checked: Nov 19, 2026Latest source record: Sep 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

4,200

Planned (sponsor's estimate)

Start

Mar 14, 2016

Primary completion

Dec 31, 2027

Study completion Dec 31, 2028

Sponsor

Lead sponsor
American Society of Clinical OncologyAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
AstraZeneca; Bayer; Bristol-Myers Squibb; Eli Lilly and Company; Genentech, Inc.; Pfizer; Taiho Oncology, Inc.; Novartis; Merck Institute for Therapeutic Research; Boehringer Ingelheim; Seattle Genetics (now a wholly owned subsidiary of Pfizer)
First posted
Feb 26, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of the study is to learn from the real world practice of prescribing targeted therapies to patients with advanced cancer whose tumor harbors a genomic variant known to be a drug target or to predict sensitivity to a drug. NOTE: Due to character limits, the arms section does NOT include all TAPUR Study relevant biomarkers. For additional information, contact TAPUR@asco.org, or if a patient, your nearest participating TAPUR site (see participating centers). \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\* Results in publication or poster presentation format are posted as they become available for individual cohorts at www.tapur.org/news. The results may be accessed at any time. All results will be made available on clinicaltrials.gov at the end of the study. Indexing of available results on PubMed is in progress. \*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*\*

Conditions

  • Lymphoma, Non-Hodgkin
  • Multiple Myeloma
  • Advanced Solid Tumors

Interventions

  • Sunitinib (CLOSED TO ENROLLMENT)Drug

    drug

  • Trastuzumab and Pertuzumab (CLOSED TO ENROLLMENT)Drug

    drug

  • Vemurafenib and Cobimetinib (CLOSED TO ENROLLMENT)Drug

    drug

  • Olaparib (CLOSED TO ENROLLMENT)Drug

    drug

  • Nivolumab and Ipilimumab (CLOSED TO ENROLLMENT)Drug

    drug

  • Abemaciclib (CLOSED TO ENROLLMENT)Drug

    drug

  • Talazoparib (CLOSED TO ENROLLMENT)Drug

    drug

  • Atezolizumab and Talazoparib (CLOSED TO ENROLLMENT)Drug

    drug

  • Tucatinib plus Trastuzumab Subcutaneous (SC) (CLOSED TO ENROLLMENT)Drug

    drug

  • FutibatinibDrug

    drug

  • Dabrafenib plus TrametinibDrug

    Drug

  • Fam-Trastuzumab Deruxtecan-Nxki (TDxD)Drug

    Drug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective Response Rate defined as % of participants in a cohort with complete or partial response or with stable disease according to standard response criteriaTime frame: Assessed at 16 weeks of treatment

Locations

181 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham Comprehensive Cancer Center

    Birmingham, Alabama · Recruiting

  • Cancer Treatment Centers of America-Phoenix

    Phoenix, Arizona · Recruiting

  • Sutter Auburn

    Auburn, California · Recruiting

  • Sutter Alta Bates

    Berkeley, California · Recruiting

  • The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate

    Los Angeles, California · Recruiting

  • Kaiser Permanente - Oakland Medical Center

    Oakland, California · Recruiting

  • Sutter Palo Alto Medical Foundation: Palo Alto

    Palo Alto, California · Recruiting

  • Kaiser Permanente - Roseville Medical Center

    Roseville, California · Recruiting

  • Sutter Roseville

    Roseville, California · Recruiting

  • Kaiser Permanente - Sacramento Medical Center

    Sacramento, California · Recruiting

  • Sutter Sacramento

    Sacramento, California · Recruiting

  • Kaiser Permanente - South San Francisco Medical Center

    San Francisco, California · Recruiting

  • California Pacific Medical Center Research Institute

    San Francisco, California · Recruiting

  • Kaiser Permanente - San Francisco Medical Center

    San Francisco, California · Recruiting

  • Sutter Cancer Research Consortium

    San Francisco, California · Recruiting

  • Kaiser Permanente - San Jose Medical Center

    San Jose, California · Recruiting

  • Kaiser Permanente - San Leandro Medical Center

    San Leandro, California · Recruiting

  • Sutter Sansum Clinic

    Santa Barbara, California · Recruiting

  • Kaiser Permanente - Santa Clara Medical Center

    Santa Clara, California · Recruiting

  • Sutter Palo Alto Medical Foundation: Santa Cruz

    Santa Cruz, California · Recruiting

  • Sutter Palo Alto Medical Foundation: Fremont

    Santa Cruz, California · Recruiting

  • Sutter Palo Alto Medical Foundation: Sunnyvale

    Sunnyvale, California · Recruiting

  • Kaiser Permanente - Vallejo Medical Center

    Vallejo, California · Recruiting

  • Kaiser Permanente - Walnut Creek Medical Center

    Walnut Creek, California · Recruiting

  • Saint Vincent's Medical Center (SVMC)

    Bridgeport, Connecticut · Recruiting

  • Hartford Hospital

    Hartford, Connecticut · Recruiting

  • Midstate Medical Center (MSMC)

    Meriden, Connecticut · Recruiting

  • The Hospital of Central Connecticut (HOCC) Cancer Center

    New Britain, Connecticut · Recruiting

  • William W. Backus Hospital

    Norwich, Connecticut · Recruiting

  • Charlotte Hungerford

    Torrington, Connecticut · Recruiting

  • Windham Hospital (WH)

    Willimantic, Connecticut · Recruiting

  • Florida Cancer Specialists North / Sarah Cannon Research Institute

    Altamonte Springs, Florida · Active not recruiting

  • University of Miami/Sylvester Cancer Institute - Aventura

    Aventura, Florida · Recruiting

  • Florida Cancer Specialists South / Sarah Cannon Research Institute

    Bonita Springs, Florida · Active not recruiting

  • Florida Cancer Specialists South / Sarah Cannon Research Institute

    Bradenton, Florida · Active not recruiting

  • Florida Cancer Specialists North / Sarah Cannon Research Institute

    Brandon, Florida · Active not recruiting

  • Florida Cancer Specialists South / Sarah Cannon Research Institute

    Cape Coral, Florida · Active not recruiting

  • Florida Cancer Specialists North / Sarah Cannon Research Institute

    Clearwater, Florida · Active not recruiting

  • University of Miami/Sylvester Cancer Institute - Lennar

    Coral Gables, Florida · Recruiting

  • University of Miami/Sylvester Cancer Institute - Deerfield Beach

    Deerfield Beach, Florida · Recruiting

Showing 40 of 181 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.